FindTrial
Sign In

Investigation of adherence to eyedrops in patients with glaucoma

Investigation of adherence to treatment in patients with glaucoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7r2r7n
Enrollment
Unknown
Registered
2020-05-19
Start date
2018-04-24
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Questionnaire about barriers regarding the eyedrop usage. Use of eletronic monitoring system devices to monitore eyedrop use. Inclusion of 100 patients.
Behavioural
Device
F01.100.150.750.500.600.500
E05.318.308.980

Sponsors

Allergan
Lead Sponsor
Allergan
Collaborator

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Will be included in the glaucoma group: patients older than 18 years and one day ; the patients with glaucoma, defined by the presence of optic neuropathy with glaucoma typical changes (optic disc excavation greater than 0.6, optical disc excavation asymmetry greater than 0.2, atrophy of the nerve fiber layer, localized loss of the neuroretinal rhyme) , and with changes in the white to white perimetry examination; patients taking at least one hypotensive eye drop.

Exclusion criteria

Exclusion criteria: Patient under 18 years of age; those who have not yet been diagnosed with confirmed glaucoma; patients unable to respond to the questionnaire applied.

Design outcomes

Primary

MeasureTime frame
To evaluate objectively adherence treatment of patients with glaucoma using eletronic monitoring system devices—

Secondary

MeasureTime frame
To identify risk factors associated with non-adherence.—

Countries

Brazil

Contacts

Public ContactRicardo Abe

Hospital Oftalmologico de Brasilia

ricardoabe85@yahoo.com.br+55-061-998844060

Outcome results

None listed

Source: REBEC (via WHO ICTRP)